• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Sleep Apnea Device Recall Limits Choices

September 21, 2021 by admin

BiPAP and CPAP machines can restore health and harmony to the homes of sleep apnea sufferers. Hannah Fullmer of WHYY in Philadelphia recently wrote about the effects of a major recall on device users.

The Phillips Respironics Device Recall

The article discusses the difficult position of sleep apnea and other patients affected by the June 2021 recall by Phillips Respironics. The recall affects machines to treat both sleep apnea and respiratory failure. With a 12 month timeline for replacing the devices, patients face a situation with no easy remedy.

The recall stems from degrading sound-dampening foam. As it degrades the foam becomes black, inhalable particles that can cause a variety of health problems. Ranging from irritation to headaches and asthma, the particles may also cause cancer.

Sleep Apnea Patients Make Difficult Choices

Fullmer interviewed a Philadelphia resident who uses a BiPAP machine to treat his sleep apnea. If he stops using his machine he suffers from poor, interrupted sleep. The result is daytime sleepiness and irritability. 

In this case, it also creates an accident hazard, as this patient spends a lot of time on the road. He is torn between continuing to use a potentially dangerous device or leaving his serious condition untreated.

The recall received an FDA classification of Class 1. This level is indicated when “there is a reasonable probability that the product could cause serious health consequences or death.”

Patients like the man interviewed by Fullmer report frustration with the lack of organized communication about the recall and their options.

Options for Device Users

For many sleep apnea patients and others who rely on these devices, there are few good options. Some may qualify for a replacement device. This can be costly, however, and supply has dwindled.

Most patients end up choosing between using a potentially dangerous device and leaving their condition untreated. Fullmer talked to Dr. Fred Jaffe, a sleep physician at Temple Health, who recommended that device users talk to their doctors.

For some patients, dental and other positional devices may be effective during the wait. For others, stopping device usage is a serious risk to their health.

The recommended option will vary based on the seriousness of the condition being treated. Patients and their doctors are put in the uncomfortable position of deciding if the risks of treatment are less than or greater than the risks of the condition.

 

Sources:

https://whyy.org/articles/recall-of-sleep-apnea-aids-leaves-some-people-feeling-stuck-between-two-risky-choices/

https://www.usa.philips.com/healthcare/e/sleep/communications/src-update

https://www.fda.gov/medical-devices/safety-communications/certain-philips-respironics-ventilators-bipap-and-cpap-machines-recalled-due-potential-health-risks#actions

Filed Under: Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy